HEPHAISTOS-Pharma
PrivateLast Round
Seed
May 16, 2024
Total Funding Raised
$4.88M
Momentum Score
25 /100
Company Overview
HEPHAISTOS-Pharma is a biotechnology company focused on developing innovative oncology treatments through a platform that enhances immune responses and transforms cold tumors into targets for effective cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HEPHAISTOS-Pharma Comps
Public and private peers based on sector, stage, and business model.
HEPHAISTOS-Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 16, 2024 |
Key People
Founding team and executive leadership
HEPHAISTOS-Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Seed |
| xista science ventures | Seed |
| Elaia Partners | Seed |
| Angels Santé | Seed |
| Femmes Business Angels | Seed |
| Fondation Fournier-Majoie | Seed |
HEPHAISTOS-Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HEPHAISTOS-Pharma's valuation, stock price, and market status.
